Pityriasis rosea-like Drug Eruption Induced by Imatinib Mesylate (Gleevec™)

Imatinib mesylate (Gleevec™, STI571), a selective inhibitor of BCR-ABL, c-Kit, and platelet-derived factor receptor, has been used to treat chronic myelogenous leukemia (CML) and gastrointestinal stromal tumors. Although its use has been associated with various adverse cutaneous reactions, pityriasi...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Ah Young, Kim, Dae Hun, Im, Myung, Lee, Young, Seo, Young Joon, Lee, Jeung Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Dermatological Association; The Korean Society for Investigative Dermatology 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276797/
https://www.ncbi.nlm.nih.gov/pubmed/22346278
http://dx.doi.org/10.5021/ad.2011.23.S3.S360
_version_ 1782223407284224000
author Cho, Ah Young
Kim, Dae Hun
Im, Myung
Lee, Young
Seo, Young Joon
Lee, Jeung Hoon
author_facet Cho, Ah Young
Kim, Dae Hun
Im, Myung
Lee, Young
Seo, Young Joon
Lee, Jeung Hoon
author_sort Cho, Ah Young
collection PubMed
description Imatinib mesylate (Gleevec™, STI571), a selective inhibitor of BCR-ABL, c-Kit, and platelet-derived factor receptor, has been used to treat chronic myelogenous leukemia (CML) and gastrointestinal stromal tumors. Although its use has been associated with various adverse cutaneous reactions, pityriasis rosea-like drug eruptions are rare. Here, we report a case of pityriasis rosea-like drug eruption that developed following the administration of imatinib mesylate to treat CML.
format Online
Article
Text
id pubmed-3276797
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Korean Dermatological Association; The Korean Society for Investigative Dermatology
record_format MEDLINE/PubMed
spelling pubmed-32767972012-02-16 Pityriasis rosea-like Drug Eruption Induced by Imatinib Mesylate (Gleevec™) Cho, Ah Young Kim, Dae Hun Im, Myung Lee, Young Seo, Young Joon Lee, Jeung Hoon Ann Dermatol Case Report Imatinib mesylate (Gleevec™, STI571), a selective inhibitor of BCR-ABL, c-Kit, and platelet-derived factor receptor, has been used to treat chronic myelogenous leukemia (CML) and gastrointestinal stromal tumors. Although its use has been associated with various adverse cutaneous reactions, pityriasis rosea-like drug eruptions are rare. Here, we report a case of pityriasis rosea-like drug eruption that developed following the administration of imatinib mesylate to treat CML. Korean Dermatological Association; The Korean Society for Investigative Dermatology 2011-12 2011-12-27 /pmc/articles/PMC3276797/ /pubmed/22346278 http://dx.doi.org/10.5021/ad.2011.23.S3.S360 Text en Copyright © 2011 Korean Dermatological Association; The Korean Society for Investigative Dermatology http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Cho, Ah Young
Kim, Dae Hun
Im, Myung
Lee, Young
Seo, Young Joon
Lee, Jeung Hoon
Pityriasis rosea-like Drug Eruption Induced by Imatinib Mesylate (Gleevec™)
title Pityriasis rosea-like Drug Eruption Induced by Imatinib Mesylate (Gleevec™)
title_full Pityriasis rosea-like Drug Eruption Induced by Imatinib Mesylate (Gleevec™)
title_fullStr Pityriasis rosea-like Drug Eruption Induced by Imatinib Mesylate (Gleevec™)
title_full_unstemmed Pityriasis rosea-like Drug Eruption Induced by Imatinib Mesylate (Gleevec™)
title_short Pityriasis rosea-like Drug Eruption Induced by Imatinib Mesylate (Gleevec™)
title_sort pityriasis rosea-like drug eruption induced by imatinib mesylate (gleevec™)
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3276797/
https://www.ncbi.nlm.nih.gov/pubmed/22346278
http://dx.doi.org/10.5021/ad.2011.23.S3.S360
work_keys_str_mv AT choahyoung pityriasisrosealikedrugeruptioninducedbyimatinibmesylategleevec
AT kimdaehun pityriasisrosealikedrugeruptioninducedbyimatinibmesylategleevec
AT immyung pityriasisrosealikedrugeruptioninducedbyimatinibmesylategleevec
AT leeyoung pityriasisrosealikedrugeruptioninducedbyimatinibmesylategleevec
AT seoyoungjoon pityriasisrosealikedrugeruptioninducedbyimatinibmesylategleevec
AT leejeunghoon pityriasisrosealikedrugeruptioninducedbyimatinibmesylategleevec

Ejemplares similares